Loading organizations...
§ Private Profile · Dresden, Sachsen, Germany
Develops and manufactures compact point-of-care fluid analysis systems for diagnostic testing across human medicine and industries.
Based in Dresden, Germany, anvajo develops and manufactures portable point-of-care fluid analysis devices that combine microscopy and spectrometry into a single integrated unit. The company provides proprietary hardware, such as the fluidlab R-300 platform, alongside single-use sample carriers and software solutions for diagnostic testing in human medicine, veterinary care, and environmental water analysis. Operating with an estimated workforce of 51 to 100 employees, the enterprise enables users to analyze liquids directly at the sampling site without requiring traditional laboratory infrastructure. To scale its commercialization and hardware manufacturing efforts, the organization secured €17.7 million in Series A financing through a funding round led by corporate venture arms Johnson & Johnson Innovation and Evonik Venture Capital. Originating as a spin-off from the Technical University of Dresden, anvajo was founded in 2016 by Stefan Fraedrich and Felix Lambrecht.
anvajo has raised $17.3M across 1 funding round.
anvajo has raised $17.3M in total across 1 funding round.
anvajo has raised $17.3M across 1 funding round. Most recently, it raised $17.3M Series A in October 2022.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Oct 21, 2022 | $17.3M Series A | — | Brueckenkoepfe Management, Elber Beteiligungen, Johnsonville Holdings, Medice Arzneimittel, Think.health Ventures | Announced |
anvajo has raised $17.3M in total across 1 funding round.
anvajo's investors include BrueckenKoepfe Management, Elber Beteiligungen, Johnsonville Holdings, Medice Arzneimittel, Think.Health Ventures.